RE:RE:RE:RE:Now Thursday has to make them think twice I rarely buy based on Pe ratio as i invest in mostly growth companies and like to filter out tax assets etc to get a better idea of operating profits from the base business. I look at cash on hand, cash available from options, company management, and deal metrics to see where i think the company can be 6-12 months out all things considered. To each their own, but it has served me well. By the metrics i use, Phm is cheaper than its ever been and better positioned than ever for an incredible year and we're not through June. Cheapest healthcare stock i own and should have the highest growth rate from what i can measure provided deal metrics continue to keep inline with what they have been thus far.